Depending on targeted treatment goals , GHK-Cu may be utilized topically, intranasally, or through subcutaneous and IV delivery
Still, BPC-157 is not a one-size-fits-all solution
In preclinical models, KLOW provides simultaneous input into cytoprotective growth factor pathways (BPC-157), actin-regulated cell migration (TB-500), melanocortin-mediated anti-inflammatory suppression (KPV), and copper-dependent collagen and antioxidant gene activation (GHK-Cu)
This is critical for tendons and ligaments, which have notoriously poor blood supply
2020 Dec
This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such